Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
national top stories
new york blog main
5
×
boston blog main
boston top stories
new york top stories
fda
abbvie
allergan
drugs
merck
national
new york
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
acorda therapeutics
allopregnanolone
amgen
ampyra
apokyn
apomorphine
biohaven
biotech
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brexanolone
bristol-myers squibb
cancer
cgpr
clinical data
companion diagnostic
dalfampridine
detroit blog main
detroit top stories
What
approved
5
×
new
5
×
drug
fda
medicine
disease
nod
oks
treatment
acorda
adults
allergan
brexanolone
cancer
class
cope
data
deeper
depression
devastating
disorder
dna
episodes
fast
fatty
fingerprint
friday
genetic
gets
going
help
horizon
intercept
known
late
liver
looms
marketed
matter
meant
Language
unset
Current search:
new
×
" new york blog main "
×
approved
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues